DEPOMED (NASDAQ:DEPO)
3.30
+0.03 (0.92%)
| DEPOMED (NASDAQ:DEPO) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $3.27 | 52 Week High | $6.40 | ||
| Open | $3.25 | 52 Week Low | $1.01 | ||
| Day High | $3.30 | P/E | N/A | ||
| Day Low | $3.24 | EPS | $-0.58 | ||
| Volume | 291,783 | ||||
| More DEPO Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| BOOM | 4 | BBW | 3 |
| FOLD | 3 | PODD | 2 |
| APKT | 2 | FTBK | 2 |
| SHAW | 2 | WMGI | 2 |
| SMSI | 2 | SYMC | 2 |
| DCAI | 2 | ATHN | 2 |
Entities who have mentioned DEPO
- Merriman Curhan Ford | View Related Stories »
- Third Point LLC | View Related Stories »
- Daniel Loeb | View Related Stories »
- David Einhorn | View Related Stories »
- GLG Partners | View Related Stories »
- Dividend | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Deutsche Bank | View Related Stories »
- Citi | View Related Stories »
- Greenlight Capital | View Related Stories »
- Morningstar, Inc. | View Related Stories »
- CIBC | View Related Stories »
- Trading Radar | View Related Stories »
- Standard & Poor's | View Related Stories »
- After-Hours Movers | View Related Stories »
- JPMorgan | View Related Stories »
- Needham & Co | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Nelson Peltz | View Related Stories »
- BMO Capital | View Related Stories »
- Trian Fund | View Related Stories »
- Morgan Stanley | View Related Stories »
- 13D | View Related Stories »
- Merrill Lynch | View Related Stories »
- Hedge Funds | View Related Stories »
View All Major News StreetInsider.com Major News for DEPO
- Depomed (DEPO) Tops Q3 EPS by 11c on Strong Revenues
- Depomed (DEPO) Misses Q2 EPS by 1c
- Depomed (DEPO) Tops Q1 EPS by 2c
View All ReportsStreetInsider.com Reports on DEPO
- Depomed (DEPO) Receives Paragraph IV Notice from Lupin Limited Over Patent Filing for Generic Glumetza Tablets
- After-Hours Movers 10/29: AXTI, ISSI, APKT, GNW, CEC, CSA, LVS Higher; IDIX, NVTL, TSRA, CRDC Lower
- Depomed (DEPO) Tops Q3 EPS by 11c on Strong Revenues
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- Caris & Co Initiates Coverage on DepoMed (DEPO) with a Buy
View All Press ReleasesCompany Press Releases on DEPO
- Depomed Promotes William Callahan to Vice President of Operations
- Depomed Ranked #13 on Deloitte's Technology Fast 500TM
- Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R)
- Depomed to Present at Merriman Curhan Ford's Investor Summit 2009
- Depomed Reports Third Quarter 2009 Financial Results
StreetInsider Reports on DEPO by Category
View All BlogsBlogs on DEPO
- Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
- Serada Half Price Sale: DepoMed's Stock Price Poised to Climb
- Movers and Shakers Include Flu Stocks Sinovac and BioCryst Pharma
- Depomed sinks on dismal drug news
- BioMimetic Leads Tuesday's Healthcare Winners
View All FilingsSEC Filings on DEPO
- Form 8-K DEPOMED INC For: Nov 09
- Form 10-Q DEPOMED INC For: Sep 30
- Form 8-K DEPOMED INC For: Oct 29
- Form 4 DEPOMED INC For: Oct 21 Filed by: STERN JULIAN N
Comments on DEPO
No comments are currently available.
